Oxford Immunotec selected to test new entrants for TB in UK national tender

Oxford Immunotec have been selected by NHS England to provide tuberculosis (TB) testing for persons recently immigrating to England as part of the National Health Service’s (NHS) new strategy for TB control in England. The NHS’s new strategy comes in response to growing TB rates in England and represents a significant new initiative in the fight to control this deadly infection.

The NHS issued a tender for laboratories and other service providers to bid for contracts to test for latent tuberculosis infection (LTBI) in 16 to 35 year olds who recently arrived in England from high TB incidence countries. The tender lasts for a minimum of three years, with estimated testing volumes of approximately 50,000 tests/year. The tender included only interferon-gamma release assays, or IGRAs. The tuberculin skin test was not considered for this program.

Oxford Immunotec have been appointed in six out of eight regions

  • North East, Yorkshire & Humber (sole provider)
  • North West (sole provider)
  • East of England (sole provider)
  • South West (sole provider)
  • West Midlands
  • London

Winning bidders in each region were selected on the basis of service capability, quality and price. Oxford Immunotec will provide T-SPOT®.TB testing services from its Oxford Diagnostic Laboratories (ODL®) in the United Kingdom.

ODL will provide educational, administrative and logistical support to the local implementation teams.

For further information please contact 01235 442780 or email uksales@oxfordimmunotec.com.

If you require more information on the NHS programe please visit NHS England FAQ Page.

 

The Oxford Immunotec logo is a registered trademark of Oxford Immunotec Ltd.

 

 

 

 

 

Oxford Diagnostic Laboratories
are a Trading Division of Oxford Immunotec Ltd.

U.S. Headquarters | Int'l Headquarters

Labs Conducting the T-SPOT.TB Test

Innovative Products and Solutions